$70M Risperdal Verdict
In the Philly Inquirer July 2, 2016: Philadelphia jury pins $70m verdict on Janssen for its Risperdal drug A Philadelphia jury found Friday that the antipsychotic drug Risperdal caused a Tennessee boy to grow breasts and imposed a $70 million verdict on its manufacturer, Janssen Pharmaceuticals. Lawyers for the boy argued that scientists for the […]
Risperdal News: Sheller Quoted in Toronto Star
Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.” In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from […]
TV: SHELLER ON PHARMA & COURTS
Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How Is Pharma Faring in the Courts?” Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller of Sheller, P.C., corporate defense counsel Terry Henry of Blank Rome and Bloomberg News Reporter Jef Feeley. In an opening feature report, […]
